4DMedical completes $150 million institutional placement

• Proceeds will be used primarily to accelerate the commercialisation of 4DMedical’s CT:VQ™ product in the U.S. • Coincident with the placement, CEO Andreas Fouras and CFO Julian Sutton have exercised options early and increased their respective shareholdings in the Company • Pro forma cash position post completion of more than $200 million provides balance sheet strength to take 4DMedical to prof